Anthropic Releases New 'Mythos-Class' Model to General Public With Guardrails

GSK to Buy Nuvalent for $10.6 Billion in Oncology Push

GSK to Buy Nuvalent for $10.6 Billion in Oncology Push

GSK to Buy Nuvalent for $10.6 Billion in Oncology Push

GSK to Buy Nuvalent for $10.6 Billion in Oncology Push

GSK to Buy Nuvalent for $10.6 Billion in Oncology Push

GSK to Buy Nuvalent for $10.6 Billion in Oncology Push

Anthropic Releases New 'Mythos-Class' Model to General Public With Guardrails

Anthropic Releases New 'Mythos-Class' Model to General Public With Guardrails

Kalshi Plans Workplace Disclosure Rule to Combat Insider Trading